Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

AVASTIN DIN 02270994

Status: Marketed
Holder: HOFFMANN-LA ROCHE LIMITED
Molecule: BEVACIZUMAB
Available to quote

Health Canada record

Active ingredient(s)BEVACIZUMAB 25 MG
Dosage formSolution
RouteIntravenous
SchedulePRESCRIPTION; SCHEDULE D
ClassHuman
ATCL01FG01 BEVACIZUMAB
Original market date02-Nov-2005
Current status date02-Nov-2005
SourceHealth Canada DPD

Establishment licence of the holder

Hoffmann-La Roche Limited — licence 100006, currently licensed, last inspection rating C (2024-06-25).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing BEVACIZUMAB

DINProductCompanyFormStrengthStatus
02522160ABEVMYBIOCON BIOLOGICS CANADA INCSolutionBEVACIZUMAB 400 MGMarketed
02522179ABEVMYBIOCON BIOLOGICS CANADA INCSolutionBEVACIZUMAB 100 MGMarketed
02522837AYBINTIOSAMSUNG BIOEPIS CO., LTDSolutionBEVACIZUMAB 400 MGMarketed
02522829AYBINTIOSAMSUNG BIOEPIS CO., LTDSolutionBEVACIZUMAB 100 MGMarketed
02520729BAMBEVIAPOTEX INCSolutionBEVACIZUMAB 100 MGMarketed
02520737BAMBEVIAPOTEX INCSolutionBEVACIZUMAB 400 MGMarketed
02567865BEVQOLVACURATEQ BIOLOGICS PRIVATE LIMITEDSolutionBEVACIZUMAB 400 MGApproved
02567830BEVQOLVACURATEQ BIOLOGICS PRIVATE LIMITEDSolutionBEVACIZUMAB 100 MGApproved
02470756MVASIAMGEN CANADA INCSolutionBEVACIZUMAB 25 MGMarketed
02470748MVASIAMGEN CANADA INCSolutionBEVACIZUMAB 25 MGMarketed
02534177VEGZELMACELLTRION INC.SolutionBEVACIZUMAB 100 MGMarketed
02534185VEGZELMACELLTRION INC.SolutionBEVACIZUMAB 400 MGMarketed
02489430ZIRABEVPFIZER CANADA ULCSolutionBEVACIZUMAB 100 MGMarketed
02489449ZIRABEVPFIZER CANADA ULCSolutionBEVACIZUMAB 400 MGMarketed

Notices of Compliance

NOCDateSubmissionReason
73572005-09-09New Drug Submission (NDS)
Request a quote for AVASTIN

How to read a Canadian DIN record